Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer

By Degirmenci M.   Karaca B.   Gorumlu G.   Durusoy R.   Demir Piskin G.   Bozkurt M.   Cirak Y.   Tunali D.   Karabulut B.   Sanli U.   Uslu R.  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 585-591

Humana Press, Inc

Access to resources Recommend Favorite

Phase I/II trial of capecitabine, oxaliplatin, and irinotecan in combination with bevacizumab in first line treatment of metastatic colorectal cancer

By  

Cancer Medicine, Vol. 2045-7634, Iss. 10, 2015-10 ,pp. : 1505-1513

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of low dose capecitabine combined to irinotecan in advanced and metastatic gastric cancer

By Farhat Fadi   Kattan Joseph   Chahine Georges   Younes Fariha   Nasr Fadi   Mroue Raghda   Ghosn Marwan  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 722-727

Humana Press, Inc

Access to resources Recommend Favorite

A phase I trial of lomeguatrib and irinotecan in metastatic colorectal cancer

By Sabharwal A.   Corrie P.   Midgley R.   Palmer C.   Brady J.   Mortimer P.   Watson A.   Margison G.   Middleton M.  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 5, 2010-10 ,pp. : 829-835

Springer Publishing Company

Access to resources Recommend Favorite

Addition of sunitinib to cetuximab and irinotecan in patients with heavily pre-treated advanced colorectal cancer

By Qvortrup Camilla   Jensen Benny Vittrup   Jorgensen Trine Lembrecht   Nielsen Dorte   Bjerregaard Jon Kroll   Pfeiffer Per  

Acta Oncologica, Vol. 49, Iss. 6, 2010-08 ,pp. : 833-836

Informa Healthcare

Access to resources Recommend Favorite